Barcelona

• Safety and efficacy of hCD1a-CAR T (OC-1) therapy, in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoma ( … Recruiting
  2024-514591-40-00 1 2023-01-31 T-cell Acute Lymphoblastic Leukemia
• A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid … Recruiting
  2023-505065-91-00 4 2023-01-30 Advanced or Metastatic Solid Tumors including EGFR-mutated Non-Small C
• An extension study to evaluate the long-term efficacy and safety of odevixibat (A4250) in children with biliary atresia (BOLD-EXT) Recruiting
  2022-501090-39-00 5 2022-12-14 Biliary Atresia
• A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokine … Recruiting
  2023-506818-45-00 7 2022-12-13 Solid tumors that have a high incidence of Homologous Recombination (H
• Phase III, multicenter, open-label, randomized clinical trial to evaluate efficacy of Sodium Zirconium Cyclosilicate (Lokelma) compared to s … Recruiting
  2024-517631-43-00 5 2022-12-12 Hyperkalemia in patients with chronic kidney disease
• A multicenter phase 1/2 study of OSE-279, a PD-1 blocking monoclonal antibody, in subjects with advanced solid tumors or lymphomas Recruiting
  2024-514826-22-00 7 2022-12-05 Part A: Patients with advanced solid tumors or lymphomas.
• Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors Recruiting
  2024-513056-15-00 7 2022-12-01 Advanced Solid Tumors
• Clinical study to test the safety, tolerance and preliminary efficacy of oral ITF3756 administered alone or in combination with an anti-prot … Recruiting
  2022-501089-22-00 1 2022-11-29 Advanced solid tumors
• A study of fibrinogen concentrate (FGTW) compared to placebo in the management of bleeding in patients undergoing complex cardiac surgery Recruiting
  2024-512388-29-00 5 2022-11-29 Bleeding in patients undergoing complex cardiac surgery involving Card
• Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells Recruiting
  2023-507041-28-00 4 2022-11-28 Solid and Hematological Malignancies
• A First-in-Human Dose Escalation Study of JNJ-79635322, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated A … Recruiting
  2023-503679-12-00 1 2022-11-21 Relapsed or Refractory Multiple Myeloma
• A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic n … Recruiting
  2024-513489-20-00 5 2022-11-21 Inflammation and pain associated with ocular surgery
• A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting
  2024-514180-25-00 5 2022-11-21 unresectable or metastatic HER2+ colorectal cancer
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors Recruiting
  2022-500470-33-00 5 2022-11-14 Haemophilia
• MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex … Recruiting
  2024-514139-50-00 5 2022-11-14 Multiple myeloma
• A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neu … Recruiting
  2024-510990-21-00 10 2022-11-11 Mucopolysaccharidosis Type II [MPS II]
• Phase 1/1b study to assess the drug OBT076 in patients with recurrent and/or metastatic CD205-positive solid tumors Recruiting
  2024-511884-27-00 3 2022-11-09 CD205+ve recurrent and/or metastatic tumor types including but not lim
• Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting
  2023-508389-13-00 5 2022-11-08 Combined endpoint of all-cause mortality, kidney failure, and hospital
• A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2) Recruiting
  2024-510656-13-00 5 2022-11-08 Migraine
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece … Recruiting
  2023-504885-50-00 5 2022-11-07 Treatment of children with chronic kidney disease and proteinuria
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Che … Recruiting
  2023-504264-41-00 9 2022-11-04 CD20 positive B-Cell Non-Hodgkin Lymphoma (NHL)
• A Phase 1/2 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors … Recruiting
  2024-514266-39-00 7 2022-11-03 Advanced Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors wit
• A phase 1b/2, multicenter, adaptive, double-blind, randomized, placebo-controlled study to assess the safety, tolerability, immunogenicity, … Recruiting
  2022-500069-29-00 9 2022-11-02 Alzheimer's disease
• First-in-Human Study of RLY-2608 in Advanced Breast Cancer and Other Solid Tumors. Recruiting
  2022-500264-35-00 1 2022-10-28 Advanced solid tumor with a PIK3CA mutation in blood and/or tumor per

Showing 1,465–1,488 of 3,391 trials